These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
812 related items for PubMed ID: 7521168
1. Monoamine metabolites in normal human cerebrospinal fluid and in degenerative diseases of the central nervous system. González-Quevedo A, García JC, Fernández R, Fernández Cartaya L. Bol Estud Med Biol; 1993; 41(1-4):13-9. PubMed ID: 7521168 [Abstract] [Full Text] [Related]
2. [Concentrations of monoamines and monoamine metabolites in cerebrospinal fluid determined by high-performance liquid chromatography with electrochemical detection]. Yoshino K. No To Shinkei; 1982 Nov; 34(11):1099-106. PubMed ID: 6186264 [Abstract] [Full Text] [Related]
3. Genetics of monoamine metabolites in baboons: overlapping sets of genes influence levels of 5-hydroxyindolacetic acid, 3-hydroxy-4-methoxyphenylglycol, and homovanillic acid. Rogers J, Martin LJ, Comuzzie AG, Mann JJ, Manuck SB, Leland M, Kaplan JR. Biol Psychiatry; 2004 Apr 01; 55(7):739-44. PubMed ID: 15039003 [Abstract] [Full Text] [Related]
4. Cerebrospinal fluid kynurenic acid in male and female controls - correlation with monoamine metabolites and influences of confounding factors. Nilsson LK, Nordin C, Jönsson EG, Engberg G, Linderholm KR, Erhardt S. J Psychiatr Res; 2007 Apr 01; 41(1-2):144-51. PubMed ID: 16434056 [Abstract] [Full Text] [Related]
5. Circadian rhythm of CSF monoamines and hypocretin-1 in restless legs syndrome and Parkinson's disease. Poceta JS, Parsons L, Engelland S, Kripke DF. Sleep Med; 2009 Jan 01; 10(1):129-33. PubMed ID: 18207455 [Abstract] [Full Text] [Related]
6. Age effect on dopamine and serotonin metabolite levels in cerebrospinal fluid. Seifert WE, Foxx JL, Butler IJ. Ann Neurol; 1980 Jul 01; 8(1):38-42. PubMed ID: 6157351 [Abstract] [Full Text] [Related]
7. Monoamine precursors, transmitters and metabolites in cerebrospinal fluid: a prospective study in healthy male subjects. Eklundh T, Eriksson M, Sjöberg S, Nordin C. J Psychiatr Res; 1996 Jul 01; 30(3):201-8. PubMed ID: 8884658 [Abstract] [Full Text] [Related]
8. Cerebrospinal fluid neurotransmitter metabolites in neurologically normal infants and children. Langlais PJ, Walsh FX, Bird ED, Levy HL. Pediatrics; 1985 Mar 01; 75(3):580-6. PubMed ID: 2579365 [Abstract] [Full Text] [Related]
9. Cerebrospinal fluid monoamine metabolites during alcohol withdrawal syndrome and recovered state. Fujimoto A, Nagao T, Ebara T, Sato M, Otsuki S. Biol Psychiatry; 1983 Oct 01; 18(10):1141-52. PubMed ID: 6197099 [Abstract] [Full Text] [Related]
10. A prospective study of the association of cerebrospinal fluid monoamine metabolite levels with lethality of suicide attempts in patients with bipolar disorder. Sher L, Carballo JJ, Grunebaum MF, Burke AK, Zalsman G, Huang YY, Mann JJ, Oquendo MA. Bipolar Disord; 2006 Oct 01; 8(5 Pt 2):543-50. PubMed ID: 17042827 [Abstract] [Full Text] [Related]
11. Cerebrospinal fluid monoaminergic metabolites are elevated in adults with Down's syndrome. Kay AD, Schapiro MB, Riker AK, Haxby JV, Rapoport SI, Cutler NR. Ann Neurol; 1987 Apr 01; 21(4):408-11. PubMed ID: 2437853 [Abstract] [Full Text] [Related]
12. Simultaneous determination of DOPAC, MHPG, 5-HIAA and HVA in CSF by direct injection on a liquid chromatograph with coulometric detection. d'Eril GV, Rizzo V, Cellerino GP. Funct Neurol; 1990 Apr 01; 5(2):145-9. PubMed ID: 1699850 [Abstract] [Full Text] [Related]
13. Stability of monoamine metabolites in human cerebrospinal fluid. Langlais PJ, Bird ED, McEntee WJ. Ann Neurol; 1982 Jul 01; 12(1):48-51. PubMed ID: 6180677 [Abstract] [Full Text] [Related]
14. [A study of clinical pictures and monoamine metabolism of Gilles de la Tourette syndrome]. Takano K, Ishiguro T. Seishin Shinkeigaku Zasshi; 1993 Jul 01; 95(1):1-29. PubMed ID: 7685527 [Abstract] [Full Text] [Related]
15. Quetiapine and norquetiapine in plasma and cerebrospinal fluid of schizophrenic patients treated with quetiapine: correlations to clinical outcome and HVA, 5-HIAA, and MHPG in CSF. Nikisch G, Baumann P, Wiedemann G, Kiessling B, Weisser H, Hertel A, Yoshitake T, Kehr J, Mathé AA. J Clin Psychopharmacol; 2010 Oct 01; 30(5):496-503. PubMed ID: 20814316 [Abstract] [Full Text] [Related]
16. Cerebrospinal fluid levels of monoamine metabolites. A preliminary study of their relation to menstrual cycle phase, sex steroids, and pituitary hormones in healthy women and in women with premenstrual syndrome. Eriksson E, Alling C, Andersch B, Andersson K, Berggren U. Neuropsychopharmacology; 1994 Nov 01; 11(3):201-13. PubMed ID: 7532413 [Abstract] [Full Text] [Related]
17. Analysis of neurotransmitter metabolite concentrations in canine cerebrospinal fluid. Vaughn DM, Coleman E, Simpson ST, Satjawatcharaphong C. Am J Vet Res; 1988 Aug 01; 49(8):1302-6. PubMed ID: 2459997 [Abstract] [Full Text] [Related]
18. Cerebrospinal fluid monoamine metabolite levels in human newborn infants born in winter differ from those born in summer. Chotai J, Murphy DL, Constantino JN. Psychiatry Res; 2006 Dec 07; 145(2-3):189-97. PubMed ID: 17074397 [Abstract] [Full Text] [Related]
19. Monoamine metabolites in cerebrospinal fluid during acute cerebral ischemia. Tang HZ, Lu XF, Wang KJ, Ou YS, Huang YQ. Chin Med J (Engl); 1989 Jan 07; 102(1):18-23. PubMed ID: 2475306 [Abstract] [Full Text] [Related]
20. Effect of vagus nerve stimulation on cerebrospinal fluid monoamine metabolites, norepinephrine, and gamma-aminobutyric acid concentrations in depressed patients. Carpenter LL, Moreno FA, Kling MA, Anderson GM, Regenold WT, Labiner DM, Price LH. Biol Psychiatry; 2004 Sep 15; 56(6):418-26. PubMed ID: 15364040 [Abstract] [Full Text] [Related] Page: [Next] [New Search]